1 In the present study, we determined whether ETA receptors are present on endothelial cells in situ, by use of front-surface fluorometry of fura-2-loaded porcine aortic valvular strips and reverse transcription polymerase chain reaction (RT-PCR). 2 Although endothelin-l (ET-1) and endothelin-3 (ET-3) induced maximum elevations of cytosolic Ca2+ concentrations ([Ca2 ],) at 10' M, the peak elevations of [Ca2 ], induced by ET-1 were much greater than those induced by ET-3.
Introduction
Endothelin (ET) was originally described as a potent vasoconstrictor present in the conditioned medium of porcine cultured aortic endothelial cells (Yanagisawa et al., 1988) . Subsequent studies led to the discovery of three isoforms of ET (ET-1, -2 and -3), which are different not only in structure but also in function (Inoue et al., 1989) . Radioligand binding studies (Watanabe et al., 1989) , as well as pharmacological studies (Inoue et al., 1989; Warner et al., 1989) suggested the presence of several subtypes of ET receptors. Recently two distinct ET receptor subtypes have been cloned, one of which preferentially binds to ET-1 and to ET-2 (Arai et al., 1990) while the other binds to ET-1, -2 and -3, with equal affinity (Sakurai et al., 1990) . It has been recommended that the former be called the ETA subtype and the latter be called the ETB subtype (Vane, 1990) . As to the implications of ETs for the cardiovascular systems, it has been postulated that ETA and ETB receptors are present on smooth muscle cells and are responsible for vasoconstriction, while ETB receptors are present on endothelial cells and may be responsible for the release of endothelium-derived relaxing factor (EDRF) (Masaki et al., 1991; Ushio-Fukai et al., 1992; Remuzzi & Benigni, 1993) or prostaglandin I2 . However, subtypes of ET receptors on endothelial cells have required further study. Physiological or pharmacological studies have indicated the presence of ETA (Vigne et al., 1990; 1991; Amano et al., 1994) , ETB Fujitani et al., 1992) and ETc (ET-3-specific, Emori et al., 1990; Warner et al., 1992) receptor subtypes in endothelial cells. The expression of ETB receptor mRNA in endothelial cells has been reported (Ogawa et al., 1991) , but not the expression of ETA receptor mRNA in en-'Author for correspondence.
dothelial cells. Here we show the presence of functioning ETA receptors and the expression of ETA receptor mRNA in endothelial cells in situ.
We recently developed a new method of investigating Ca2" metabolism of endothelial cells in situ, using porcine aortic valve leaflets loaded with fura-2 and front-surface fluorometry (Aoki et al., 1991; Kuroiwa et al., 1993) . Using this method, we found that ET-1 caused a much greater elevation of [Ca2"]i than ET-3, at equimc'ar concentrations (Aoki et al., 1991) . However, if endothelial cells possess a single class of ETB receptor subtype, ET-1 and ET-3 at an equimolar concentration should elicit a similar size of Ca2+ transients, since the ETB receptor subtype has an equally high affinity for and ET-3. To explain this greater response of [Ca2+] , induced by ET-1, we entertained the notion that endothelial cells may have an additional ET receptor subtype other than the ETB receptor subtype.
In the present study, we characterized Ca2+ transients induced by ET-1 and ET-3 and the effect of BQ-123, a selective ETA receptor antagonist (Ihara et al., 1992) on these transients, the objective being to determine ET receptor subtypes in endothelial cells in situ. In the case of the investigation of the additivity of ET-1 and ET-3, the sustained phase of these Ca2" transients were mainly studied, because of the difficulties in investigating the rapid transient phase. These pharmacological investigations indicated that ETA receptors are present in endothelial cells on the aortic side of the porcine aortic valve. We attempted to detect the ETA receptor mRNA in endothelial cells at the aortic side of porcine aortic valve. Since the sequence of pig ETA receptor mRNA has not been described, we determined the sequence of pig ETA receptor cDNA by PCR using the known cDNA sequences of ETA receptor from other species (Arai et al., 1990; Lin et al., 1991; Hosoda et al., 1991; Adachi et al., 1991) and designed specific primers for pig ETA British Journal of Pharmacology (1995) 115, [1369] [1370] [1371] [1372] [1373] [1374] [1375] [1376] receptors. Using specific primers for pig ETA receptors and total RNA from the endothelial cells on the porcine aortic valve, RT-PCR revealed that ETA receptor mRNA is present in the endothelial cells from the porcine aortic valve. This is the first account of the presence of functioning ETA receptors and ETA receptor mRNA in endothelial cells.
Methods
Tissue preparation for fura-2 fluorometry Aortic roots with an intact aortic valve from adult pigs of either sex were obtained from a local slaughterhouse immediately after the animals had been killed. These roots were placed in ice-cold normal physiological salt solution (PSS) and brought to our laboratory. Usually, 1-2 h elapsed between the animal being killed and the loading of fura-2. The millimolar composition of the normal PSS was: NaCl 123, KCl 4.7, NaHCO3 15.5, KH2PO4 1.2, MgCl2 1.2, CaCl2 1.25 and Dglucose 11.5. The leaflets of the aortic valve were cut in parallel with the midline to obtain approximately 2 mm (width) x 5 mm (length) valvular strips. The centre of each leaflet, corpus aranti, was not used. The thickness of the strips was about 0.18 mm (Aoki et al., 1991) . We have already described the microscopic verification of the endothelial cells on the aortic side of the aortic valve, shown by the specific uptake of acetylated-low density lipoprotein labelled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate (DiI-Ac-LDL) and fura-2 in cells with a cobble-stone lining on the surface of the valvular strips. (Aoki et al., 1994) .
Fura-2 fluorometry
The strips were incubated for 90 min (37°C) in Dulbecco's modified Eagle's medium, gassed with 5% CO2 and 95% 02, containing 5% foetal bovine serum, 1 mM probenecid (Di Virgilio et al., 1989) and 50 pM acetoxymethyl ester of fura-2 (fura-2/AM). After loading with fura-2, the strips were washed at least 5 times with normal PSS and equilibrated for 1 h at room temperature. Each strip was mounted in a strip holder in a quartz organ bath filled with normal PSS gassed with 5% CO2 and 95% 02. The experimental procedures were carried out at 25°C to prevent leakage of the fluorescence dye. Microscopic observation revealed that fura-2 was loaded only in endothelial cells of the sample. Changes in [Ca2+] i were monitored with a front-surface fluorometer (CAM-OF-1; designed in collaboration with the Japanese Spectroscopic Co., Tokyo, Japan), as described elsewhere (Hirano et al., 1990; Aoki et al., 1991) . In brief, the aortic surface of the strip was illuminated by guiding the alternating (400 Hz), 340 nm and 380 nm, excitation light from a xenon light source through quartz optic fibres arranged in a concentric inner circle (diameter: 3 mm). Surface fluorescence of the strip was collected by glass optic fibres arranged in an outer circle (diameter: 7 mm) and introduced through a 500 nm band-pass filter into a photon-counting photomultiplier. Fluorescence intensities (500 nm) at 340 nm (F340) and 380 nm (F380) excitation and its ratio (R = F340/F380) were continuously recorded. [Ca2+] , was calculated according to the method described by Grynkiewicz et al. (1985) . The apparent dissociation constant (Kd) of the fura-2:Ca2+ complex at 25°C was 162.0 ± 7.5 nM, determined spectroscopically (Fluoresence Spectrophotometer 650-40; HITACHI, Japan). and the resting level and the peak level of the fluorescence ratio were designated 0% and 100%, respectively.
[Ca2+]i levels at 0% and 100% were determined separately and were 65.3 ± 7.5 nM and 185.9 ± 20.8 nm, respectively (n = 10) (Aoki et al., 1991) .
Cloning of the pig lung ETA receptor A part of the lung from an adult pig was obtained from a local slaughterhouse immediately after the animal had been killed.
Total RNA was prepared by homogenization with Polytron in guanidinium thiocyanate, extraction with phenol/chloroform and precipitation from isopropanol, according to the method described by Chomczynski & Sacchi (1987 (Table 1 ). This double stranded cDNA with Eco RI cassette was amplified using indicated primers. Each PCR product was purified by electrophoresis through a 3% NuSieve agarose gel, cleaned by Gene Clean II, and subcloned into pCR II plasmid vector, using a TA Cloning Kit. cDNA inserts were then sequenced using a T7 Sequencing Kit, as described by the manufacturer. When determining the cDNA sequence, at least 5 clones were checked to avoid misreading due to possible misincorporation by Taq polymerase. Since cDNA sequences for ETA receptor for bovine (Arai et al., 1990) , rat (Lin et al., 1991) and man (Hosoda et al., 1991; Adachi et al., 1991) have been published, 4 primers, RS1, RS2, RAl and RA2 (Table 1) , based on the rat sequence, were designed from conserved regions among these species. First PCR was performed to determine the sequence of the core region of the pig lung ETA receptor cDNA. An aliquot of cDNA synthesized from pig lung mRNA was amplified by PCR using primers RS 1 and RA2, at reduced stringency and under thermal cycler conditions of 94°C for 30 s, 40°C for 1 min and 72°C for 2 min for a total of 40 cycles. This PCR product was purified by electrophoresis, subcloned into pCR II plasmid vector and then sequenced ( (Figure 4) . RT-PCR was performed as described elsewhere . In brief, firststrand cDNA was synthesized from total RNA obtained from porcine aortic valve endothelial cells, using M-MLV reverse transcriptase and antisense primer PA3. An aliquot of RT product was amplified by PCR using primers PS2 and PA2, under thermal cycler conditions of 94°C for 30s, 550C Detection ofpig ETE receptor mRNA in endothelial cells on the aortic side of porcine aortic valves by RT-PCR Since the sequence of the pig ETB receptor mRNA has not been described, we chose the primers, based on the rat sequence, from the conserved regions among the bovine , rat (Sakurai et al., 1990) and human (Nakamuta et al., 1991) ETB sequences. Using these primers (RSB and RAB; Table 1 ) and the total RNA prepared from the pig lung, RT-PCR gave an expected size ofband (491 bp). This PCR product was partially sequenced (data not shown). According to this sequence, we made one more primer (PSB; Table 1 ) and performed RT-PCR using the primers (PSB and RAB) and the total RNA from the endothelial cells on the aortic valve. The expected size of this PCR product was 304 bp.
Chemicals
Synthetic ET-1 and ET-3 were obtained from Peptide Institute Co. Ltd. (Osaka, Japan), sodium salt of ATP was purchased from Boehringer Mannheim (Germany), fura-2/AM and EGTA were purchased from Dojindo (Kumamoto, Japan). (cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-)) was kindly donated by Banyu Pharmaceutical Co., Ltd. (Tokyo, Japan). M-MLV (Moloney Murine Leukemia Virus) reverse transcriptase was purchased from BRL (Gaithersburg, U.S.A.). Figure la and Figure (Aoki et al., 1991; . As is obvious from these traces, at 10-7 M, the initial peak elevation of [Ca21]1 induced by ET-l was much greater than that induced by ET-3. Statistical analysis revealed that this difference was significant (P<0.05, Figure 3c ). Figures The IC50 of BQ-123 was 3 x 10-8 M and, at a concentration of I0O-M or higher, BQ-123 revealed its maximal inhibitory effect; however, it was only a partial inhibition. Since ET-1 stimulates both ETA and ETB receptors, while ET-3 preferentially stimulates ETB receptors (Vane, 1990) , it can be postulated that [Ca2"]; transients induced by ET-3 may be mediated mainly by ETB receptors. Figure 3a and spectively. Figure 3c summarizes Cloning of the pig lung ETA receptor These pharmacological experiments indicated that ETA receptors are present on endothelial cells of the porcine aortic valve. Therefore, we searched for the expression of ETA receptor mRNA in endothelial cells in situ. Since the sequence of pig ETA receptor mRNA has not been reported, we determined this sequence to design specific primers for pig ETA receptors. Figure 4 shows the sequence of pig lung ETA receptor cDNA. Similarities of the pig cDNA sequence compared with bovine (Arai et al., 1990) , rat (Lin et al., 1991) and human (Hosoda et al., 1991; Adachi et al., 1991) cDNA sequences were 92.29%, 83.49%, and 91.04% in the coding regions, respectively. The deduced amino acid sequence of pig ETA receptor was 96.96%, 92.52% and 97.20% identical to those of the bovine, rat and human ETA receptor, respectively. These findings strongly indicated that the pig ET receptor cloned in the present study belongs to the ETA subtype. , rat (Sakurai et al., 1990) and human (Nakamuta et al., 1991) ETB receptor cDNA sequences were 93.45%, 85.45% and 93.09%, respectively. These analyses strongly indicated that the PCR product obtained by these primers derived from the pig ETB receptor cDNA. These sequencing data also indicated that the pig ETH receptor cDNA preserves Eco RI site at the corresponding region of the bovine (1128-1133), rat (1128-1133) and human (1131-1136) ETB receptor cDNA.
As shown in Figure 6 , RT-PCR, using the primers PSB and RAB (Table 1 ) and the total RNA from the endothelial cells from the aortic valve, gave an expected size of band (304 bp (Aoki et al., 1991) . We observed a similar phenomenon in the present study (Figure la (Ogawa et al., 1991) . Thus, it appears that the presence of ETB receptors on endothelial cells has gained general acceptance (Masaki et al., 1991; Remuzzi & Benigni, 1993) . On the other hand, only two groups have reported the presence of ETA receptors on endothelial cells, detected in binding studies (Vigne et al., 1990 ) and functional studies (Vigne et al., 1991; Amano et al., 1994) . The expression of ETA receptor mRNA has apparently not been reported. Thus, this is a first documentation of the expression of ETA receptor mRNA in endothelial cells. It would be interesting to note that some investigators had suggested the presence of ETc receptors (ET-3-specific subtype) on cultured bovine aortic endothelial cells (Emori et al., 1990) and bovine native aortic endothelial cells (Warner et al., 1992) , detected in binding study and functional study, respectively. Recently, cDNA clone for the ETc receptor subtype has been reported in non-mammalian tissue (Karne et al., 1993) . However, the expression of ETc receptor mRNA in endothelial cells has not been reported.
In the cardiovascular system, endocardial endothelial cells and the aortic valvular endothelial cells, as well as the vascular endothelial cells, play important roles in the antithrombotic, anticoagulatory and vasorelaxant actions (Jaffe, 1985) . It has been reported that valvular endothelial cells can produce endothelium-derived relaxing factor (Ku et al., 1990; Aoki et al., 1994) . Recently, the cardiac valvular endothelial cells have been used as a model for the in situ endocardial and/or vascular endothelial cells in the investigation of the regulation of Ca2" homeostasis (Aoki et al., 1991; Laskey et al., 1994; Amano et al., 1994; Li & van Breemen, 1995) . These valvular preparations have an advantage in measuring the change in
[Ca2+]I, of the in situ endothelial cells, since there is no underlying cardiomyocytes or vascular smooth muscle cells (Aoki et al., 1994) , which, if present, would interfere the fura-2 signal. Although the clinical implication of the present study is unknown, it is tempting to speculate that ET-1, once released from endothelial cells as a vasoconstrictor, would induce large [Ca2+] , transients in the valvular endothelial cells mediated by ETA as well as ETB receptors to secrete anticoagulatory and vasorelaxant factors as an autocrine or paracrine transmitter.
In conclusion, we provide the first evidence for the presence of mRNA for the ETA receptor, which contributes to the elevation of [Ca21] , in endothelial cells in situ. Since ET-1 is the only member of the endothelin family proven to be expressed in endothelial cells ( Van, 1990) , the ETA receptor, as well as ETB receptor in endothelial cells, may play an important role in the regulating vascular tonus.
